Caffeic and Chlorogenic Acids Synergistically Activate Browning Program in Human Adipocytes: Implications of AMPK- and PPAR-Mediated Pathways.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
21 Dec 2020
Historique:
received: 24 11 2020
revised: 16 12 2020
accepted: 17 12 2020
entrez: 29 12 2020
pubmed: 30 12 2020
medline: 7 4 2021
Statut: epublish

Résumé

Caffeic acid (CA) and chlorogenic acid (CGA) are phenolic compounds claimed to be responsible for the metabolic effects of coffee and tea consumption. Along with their structural similarities, they share common mechanisms such as activation of the AMP-activated protein kinase (AMPK) signaling. The present study aimed to investigate the anti-obesity potential of CA and CGA as co-treatment in human adipocytes. The molecular interactions of CA and CGA with key adipogenic transcription factors were simulated through an in silico molecular docking approach. The expression levels of white and brown adipocyte markers, as well as genes related to lipid metabolism, were analyzed by real-time quantitative PCR and Western blot analyses. Mechanistically, the CA/CGA combination induced lipolysis, upregulated AMPK and browning gene expression and downregulated peroxisome proliferator-activated receptor γ (PPARγ) at both transcriptional and protein levels. The gene expression profiles of the CA/CGA-co-treated adipocytes strongly resembled brown-like signatures. Major pathways identified included the AMPK- and PPAR-related signaling pathways. Collectively, these findings indicated that CA/CGA co-stimulation exerted a browning-inducing potential superior to that of either compound used alone which merits implementation in obesity management. Further, the obtained data provide additional insights on how CA and CGA modify adipocyte function, differentiation and lipid metabolism.

Identifiants

pubmed: 33371201
pii: ijms21249740
doi: 10.3390/ijms21249740
pmc: PMC7766967
pii:
doi:

Substances chimiques

PPAR gamma 0
Chlorogenic Acid 318ADP12RI
AMP-Activated Protein Kinases EC 2.7.11.31

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : European Commission, H2020
ID : PlantaSYST-739582

Références

Commun Biol. 2019 Oct 24;2:389
pubmed: 31667363
EBioMedicine. 2019 Feb;40:56-66
pubmed: 30528454
Food Chem Toxicol. 2019 May;127:182-187
pubmed: 30914352
Cell. 2018 Jan 11;172(1-2):218-233.e17
pubmed: 29249357
Sci Rep. 2017 Jun 22;7(1):4031
pubmed: 28642596
EBioMedicine. 2016 Aug;10:174-84
pubmed: 27422345
Diabetes Obes Metab. 2019 Nov;21(11):2553-2563
pubmed: 31364797
Acta Pharmacol Sin. 2016 Nov;37(11):1413-1422
pubmed: 27593219
J Transl Med. 2015 Apr 30;13:135
pubmed: 25925588
Food Chem Toxicol. 2010 Mar;48(3):937-43
pubmed: 20064576
Histochem Cell Biol. 2018 Jun;149(6):593-605
pubmed: 29574488
Biochem Pharmacol. 2019 Jun;164:252-262
pubmed: 31004566
Pharmacol Res. 2019 Oct;148:104411
pubmed: 31449976
Nat Commun. 2018 Nov 8;9(1):4687
pubmed: 30409975
Diabetologia. 2019 Oct;62(10):1915-1927
pubmed: 31317231
Pharmacol Res. 2011 Aug;64(2):87-99
pubmed: 21371557
Pharmacol Res. 2020 Jun;156:104760
pubmed: 32205234
Nat Commun. 2020 May 8;11(1):2303
pubmed: 32385276
Food Chem Toxicol. 2018 Nov;121:173-193
pubmed: 30176311
Nat Commun. 2015 Jun 29;6:7433
pubmed: 26118629
FASEB J. 2020 Mar;34(3):4527-4539
pubmed: 32003501
Mol Metab. 2019 Feb;20:14-27
pubmed: 30580967
Cell Rep. 2019 Jul 16;28(3):792-803.e4
pubmed: 31315055
Am J Clin Nutr. 2010 Jul;92(1):5-15
pubmed: 20463039
EBioMedicine. 2020 Apr;54:102722
pubmed: 32268273
Nat Commun. 2016 Feb 16;7:10686
pubmed: 26880110
Biochem J. 2017 Aug 22;474(17):3059-3073
pubmed: 28694351
Diabetes. 2019 Jul;68(7):1449-1461
pubmed: 31010955
Int J Obes (Lond). 2015 Jun;39(6):967-76
pubmed: 25761413
Nat Commun. 2019 Jul 3;10(1):2936
pubmed: 31270323
Metabolism. 2020 Jun;107:154228
pubmed: 32289346
Mol Metab. 2020 Jun;36:100964
pubmed: 32248079
Cell Rep. 2020 May 5;31(5):107579
pubmed: 32375030
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4285-4290
pubmed: 30770439
Cell Rep. 2018 Dec 11;25(11):3215-3228.e9
pubmed: 30540952
Biomolecules. 2018 Jun 04;8(2):
pubmed: 29867022
Free Radic Biol Med. 2018 Feb 1;115:232-245
pubmed: 29221989
Int J Obes (Lond). 2019 Dec;43(12):2458-2468
pubmed: 31324879
Pharmacol Res. 2019 Sep;147:104393
pubmed: 31401211
Acta Pharm Sin B. 2019 Jan;9(1):135-143
pubmed: 30766785
Cell Death Differ. 2020 Oct;27(10):2921-2941
pubmed: 32382110
Redox Biol. 2019 Sep;26:101286
pubmed: 31382214
Food Chem. 2020 Dec 15;333:127528
pubmed: 32682231
Proc Natl Acad Sci U S A. 2019 Jul 23;116(30):15128-15133
pubmed: 31289228
J Lipid Res. 2014 Nov;55(11):2276-86
pubmed: 25193997
Cell Metab. 2017 Feb 7;25(2):438-447
pubmed: 28089568
Nat Commun. 2019 Aug 6;10(1):3536
pubmed: 31387996
Pharmacol Res. 2018 Apr;130:110-122
pubmed: 29408518
Nat Commun. 2020 Jan 10;11(1):213
pubmed: 31924774
Nat Commun. 2020 Jun 2;11(1):2758
pubmed: 32488069
EBioMedicine. 2016 Jul;9:61-76
pubmed: 27374313
Biomed Pharmacother. 2017 Oct;94:169-175
pubmed: 28759754
Nat Metab. 2019 Mar;1(3):340-349
pubmed: 30887000
Food Chem Toxicol. 2019 Jan;123:298-313
pubmed: 30291944
Food Chem Toxicol. 2019 Oct;132:110672
pubmed: 31306686
Nat Commun. 2020 Mar 19;11(1):1465
pubmed: 32193374
Pharmacol Res. 2017 May;119:303-312
pubmed: 28249816
Nutr Diabetes. 2016 Jun 06;6:e212
pubmed: 27270110
Biochem Pharmacol. 2013 May 1;85(9):1341-51
pubmed: 23416115
Int J Obes (Lond). 2021 Jan;45(1):122-129
pubmed: 32467614

Auteurs

Liliya V Vasileva (LV)

Department of Plant Cell Biotechnology, Center of Plant Systems Biology and Biotechnology, 4000 Plovdiv, Bulgaria.

Martina S Savova (MS)

Department of Plant Cell Biotechnology, Center of Plant Systems Biology and Biotechnology, 4000 Plovdiv, Bulgaria.
Laboratory of Metabolomics, The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 4000 Plovdiv, Bulgaria.

Kristiana M Amirova (KM)

Department of Plant Cell Biotechnology, Center of Plant Systems Biology and Biotechnology, 4000 Plovdiv, Bulgaria.
Laboratory of Metabolomics, The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 4000 Plovdiv, Bulgaria.

Zhivka Balcheva-Sivenova (Z)

Department of Plant Cell Biotechnology, Center of Plant Systems Biology and Biotechnology, 4000 Plovdiv, Bulgaria.
Laboratory of Metabolomics, The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 4000 Plovdiv, Bulgaria.

Claudio Ferrante (C)

Department of Pharmacy, G. d'Annunzio University, 66100 Chieti, Italy.

Giustino Orlando (G)

Department of Pharmacy, G. d'Annunzio University, 66100 Chieti, Italy.

Martin Wabitsch (M)

Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, 89077 Ulm, Germany.

Milen I Georgiev (MI)

Department of Plant Cell Biotechnology, Center of Plant Systems Biology and Biotechnology, 4000 Plovdiv, Bulgaria.
Laboratory of Metabolomics, The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 4000 Plovdiv, Bulgaria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH